AKIRAM THERAPEUTICS
Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer marker CD44v6 combined with a radiation component. The therapy has generated strong preclinical results in cancer models in conditions that currently lack effective treatments. With the potential for its drug candidate to be classified as an orphan drug and recognized as first-in-class, the company is dedicated to adv... ancing research in this field, including indications in head and neck cancer, AML (Acute Myeloid Leukemia), lung cancer, and aggressive thyroid cancer. Headquartered in Uppsala, Sweden, Akiram Therapeutics is staffed with experts in radiation science research, cancer precision medicine, and drug development.
AKIRAM THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Precision Medicine
Founded:
2021-06-10
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.akiramtherapeutics.se
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
67.88 M SEK
Technology used in webpage:
Japanese Yen Team.blue
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pheast Therapeutics
Pheast Therapeutics develops novel checkpoint therapies to harness the innate immune system.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Founder
Investors List
Sciety
Sciety investment in Venture Round - Akiram Therapeutics
Official Site Inspections
http://www.akiramtherapeutics.se
- Host name: linux202.unoeuro.com
- IP address: 93.191.156.77
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "Akiram Therapeutics"
About - Akiram Therapeutics
Akiram Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer …See details»
Akiram Therapeutics Company Profile 2024: Valuation, …
Akiram Therapeutics General Information Description. Developer of radiopharmaceuticals designed for advancing radio therapeutics to treat solid tumors. The company is focused on designing and developing novel …See details»
Our Team – Akiram Therapeutics
E-mail us at [email protected] Akiram Therapeutics is a Swedish biotech company committed to developing innovative and targeted molecular radiotherapy for patients with incurable cancer. Our product combines a …See details»
Akiram Therapeutics AB - Drug pipelines, Patents, Clinical trials
Explore Akiram Therapeutics AB with its drug pipeline, therapeutic area, technology platform, .See details»
Akiram Therapeutics Overview | SignalHire Company Profile
Organization Website: akiramtherapeutics.se : Akiram Therapeutics industries BiotechSee details»
Akiram Therapeutics - VentureRadar
Website: http://akiramtherapeutics.se/ Develops next generation radiopharmaceuticals for efficient visualization and treatment of solid cancers using novel ...See details»
Akiram Therapeutics - Company Profile - Tracxn
Sep 23, 2024 Akiram Therapeutics - Developer of radiopharmaceuticals for cancer treatment. Raised a total funding of $6.5M over 1 round from 4 investors. Founded by Anja Mortensen …See details»
Akiram Therapeutics AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Akiram Therapeutics AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.See details»
Company Information - RocketReach
Akiram Therapeutics is a Swedish biotech company committed to developing innovative and targeted molecular radiotherapy for patients with incurable cancer.See details»
Invest – Akiram Therapeutics
E-mail us at [email protected]. Our Therapy. Learn more about Akiram Therapeutic’s targeted cancer therapy. About Us. Explore our story and innovative approach to transforming …See details»
Akiram Therapeutics - Products, Competitors, Financials, …
Akiram Therapeutics announces agreement with leading university hospital on AKIR001 manufacturing for cancer therapy. Jan 17, 2024. Akiram Therapeutics Wed, Jan 17, 2024 …See details»
Akiram-key-data-AKIR001-trp-summit-2024-x - Cision News
Nov 28, 2024 About Us. Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary …See details»
Akiram Therapeutics - Cision News
Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer …See details»
Akiram Therapeutics raises SEK 68 million for clinical development …
Jan 12, 2023 Email: [email protected] Phone: +46 702 34 18 81. About Akiram Therapeutics Akiram Therapeutics is a Swedish biotech company focused on the …See details»
Akiram Therapeutics strengthens board with drug development …
Dec 19, 2023 Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, is pleased to announce the addition of Anna Törner and Peder Walberg to its …See details»
Akiram raises SEK 68 million - akiramtherapeutics.se
Email: [email protected] Phone: +46 702 34 18 81 About Akiram Therapeutics Akiram Therapeutics is a Swedish biotech company focused on the development …See details»
DDD exit financed with 68 MSEK to develop novel cancer therapy
Feb 8, 2023 Services. Overview Services provided by our national research infrastructure; Find services Find the right technology or expertise for your research project; Recent user …See details»
News – Akiram Therapeutics
Jan 17, 2024 Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, has entered into an agreement with a leading Swedish university hospital for the …See details»